ID: ALA4550137

Max Phase: Preclinical

Molecular Formula: C29H26N2O3

Molecular Weight: 450.54

Molecule Type: Unknown

Representations

Canonical SMILES:  CCN(CC)C(=O)OC1=C(c2ccccc2-c2ccccc2)Oc2ccccc2-n2cccc21

Standard InChI:  InChI=1S/C29H26N2O3/c1-3-30(4-2)29(32)34-28-25-18-12-20-31(25)24-17-10-11-19-26(24)33-27(28)23-16-9-8-15-22(23)21-13-6-5-7-14-21/h5-20H,3-4H2,1-2H3

Standard InChI Key:  KXWYRPGWLQIVMC-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 450.54

Molecular Weight (Monoisotopic): 450.1943

AlogP: 6.84

#Rotatable Bonds: 5

Polar Surface Area: 43.70

Molecular Species:

HBA: 4

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa:

CX LogP: 5.90

CX LogD: 5.90

Aromatic Rings: 4

Heavy Atoms: 34

QED Weighted: 0.33

Np Likeness Score: -0.35

References

1. Brindisi M, Ulivieri C, Alfano G, Gemma S, de Asís Balaguer F, Khan T, Grillo A, Chemi G, Menchon G, Prota AE, Olieric N, Lucena-Agell D, Barasoain I, Diaz JF, Nebbioso A, Conte M, Lopresti L, Magnano S, Amet R, Kinsella P, Zisterer DM, Ibrahim O, O'Sullivan J, Morbidelli L, Spaccapelo R, Baldari C, Butini S, Novellino E, Campiani G, Altucci L, Steinmetz MO, Brogi S..  (2019)  Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents.,  162  [PMID:30448418] [10.1016/j.ejmech.2018.11.004]

Source

Source(1):

• Scientific Literature